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Non-alcoholic fatty liver disease (NAFLD) is an asymptomatic increasingly
common disorder that affects liver metabolism and is often the precursor for liver
pathologies such as fibrosis, cirrhosis and hepato-cellular carcinoma. The liver sinusoidal
endothelial cells act as a liver sieve by allowing macromolecules and chylomicrons to
traverse through their fenestrations (sieve plates) to hepatocytes. Since liver sinusoidal
endothelial cells (LSEC) regulate serum derived macromolecular exposure to
hepatocytes, we asked what role LSEC could play in the pathogenesis of NAFLD. To
investigate the early events of NAFLD we used a rat model (Sprague-Dawley) in which
animals were maintained on standard and high fat diets (HFD) for a period of 8 weeks.
The lipid accumulation in the livers, isolated hepatocytes and LSEC were visualized by
Oil Red O, BODIPY (boron-dipyrromethene) stains and CARS (Coherent Anti-stokes
Raman Scattering) imaging. There was evidence of increased size of lipid droplets in the
hepatocytes of HFD rats in contrast to their LSEC, which showed minimal to no lipid
accumulation. The lipid content of the liver tissues was analyzed by thin layer
chromatography, which revealed the accumulation of triglycerides and cholesteryl esters
in the livers of HFD rats compared to the control rats. In vitro endocytosis of 125I-HA
(hyaluronic acid) experiments carried out on LSECs isolated from the rat livers showed
that the 125I-HA uptake is significantly higher in control rats compared to HFD rats. We
also observed that serum HA levels and alkaline phosphatase (ALP) levels were
increased in HFD rats, in contrast to alanine transaminase (ALT), triglycerides and
cholesterol, which remained the same. Purified RNA from the isolated LSECs was
subjected to microarray analysis demonstrating altered gene expression patterns between
rats on two different diets. The kidneys, gut, and spleens were also harvested to study the
interplay of the organs in the disease. We have been able to demonstrate that decreased
endocytic ability of LSECs precedes fibrosis of liver in NAFLD.

III

DEDICATION
To my mother, for her unwavering belief in me.

IV

ACKNOWLEDGEMENTS
I would like to thank Dr. Edward Harris for his guidance, support and
help. I would also like to thank my committee members, Dr. Concetta Dirusso and Dr.
Paul Black for their helpful suggestions and consideration.
My family and friends have been a great support to me and I would like to thank
them for it. I would also like to thank my husband, Ananth for his constant
encouragement and understanding.

V
TABLE OF CONTENTS
DEDICATION .................................................................................................................. III
ACKNOWLEDGEMENTS .............................................................................................. IV
TABLE OF CONTENTS ................................................................................................... V
LIST OF FIGURES .......................................................................................................... VI
LIST OF TABLES ............................................................................................................ VI
CHAPTER 1 ....................................................................................................................... 1
INTRODUCTION AND LITERATURE REVIEW .......................................................... 1
1.1 Liver .......................................................................................................................... 2
1.2 Cells of the liver ........................................................................................................ 2
1.3 Organization of the liver ........................................................................................... 5
1.4 Structural and functional aspects of sinusoidal endothelial cells .............................. 6
1.5 Non-Alcoholic Fatty liver disease (NAFLD) .......................................................... 12
CHAPTER 2 ..................................................................................................................... 14
ISOLATION OF LIVER SINUSOIDAL ENDOTHELIAL CELLS. .............................. 14
2.1 Introduction ............................................................................................................. 15
2.2 Materials and methods ............................................................................................ 16
2.3 Discussion ............................................................................................................... 20
CHAPTER 3 ..................................................................................................................... 23
EFFECT OF HIGH FAT DIET ON THE LIVER ............................................................ 23
3.1 Introduction ............................................................................................................. 24
3.2 Materials and methods ............................................................................................ 25
3.3 Results ..................................................................................................................... 28
3.4 Discussion ............................................................................................................... 29
CHAPTER 4 ..................................................................................................................... 41
SINUSOIDAL ENDOTHELIAL DYSFUNCTION IN FATTY LIVER DISEASE ....... 41
4.1 Introduction ............................................................................................................. 42
4.2 Materials and methods ............................................................................................ 43
4.3 Results ..................................................................................................................... 47
4.4 Discussion ............................................................................................................... 48

VI
CONCLUSIONS AND FUTURE DIRECTIONS............................................................ 58
REFERENCES ................................................................................................................. 66
LIST OF FIGURES
Fig 1: Basic architecture of the liver....................................................................................6
Fig 2: Electron micrograph of sinusoidal endothelial cells.................................................7
Fig 3: Stabilin receptors.....................................................................................................10
Fig 4: Liver cells in fibrosis...............................................................................................13
Fig 5: Assembly of perfusion apparatus............................................................................18
Fig 6: Culture of isolated liver sinusoidal endothelial cells...............................................22
Fig 7: Weight of control and high fat rats..........................................................................32
Fig 8: Abdominal exposure and visual inspection of livers...............................................34
Fig 9: Liver tissue staining.................................................................................................35
Fig 10: Blood chemistry.....................................................................................................36
Fig 11: Liver enzyme measurements.................................................................................37
Fig 12: Serum free fatty acid assay....................................................................................38
Fig 13: Lipid composition of liver tissue by TLC.............................................................39
Fig 14: Densitometry of TLC data.....................................................................................40
Fig 15: Staining of isolated hepatocytes and LSEC...........................................................52
Fig 16: SEM micrographs of livers....................................................................................53
Fig 17: Serum HA levels....................................................................................................54
Fig 18: In vitro endocytosis...............................................................................................55
Fig 19: Western blot of LSEC lysates................................................................................55
Fig 20: qPCR analysis of Stab2 expression.......................................................................57
LIST OF TABLES
Table 1: Composition of standard diet...............................................................................30
Table 2: Composition of high fat diet................................................................................31
Table 3: Blood Chemistry..................................................................................................33
Table 4: Summary list of upregulated genes......................................................................56
Table 5: Summary list of downregulated genes.................................................................56

CHAPTER 1
INTRODUCTION AND LITERATURE REVIEW

2
Chapter 1
Introduction and literature review
1.1 Liver
The liver is the largest visceral organ in humans and other higher vertebrates
contributing to about 2-5% of total body weight. It is a principal organ in the body as it
maintains the internal homeostasis in the organism. The liver participates in synthesis,
storage, export and secretion of various metabolites. Nutrients and other xenobiotics from
the intestinal system are transported to the liver where they are metabolized. The liver
clears various molecules and cells, foreign antigens and microbes from the blood stream.
It has a wide variety of functions and is important for the maintenance of metabolic
integrity of the body. The multiple functions of the mammalian liver are a combination of
exocrine, endocrine and paracrine functions, carried out by specialized cell types listed
below. All these varied functions take place in a unique structurally complex,
multicellular tissue, called the liver (1).
1.2 Cells of the liver
The liver consists of seven distinct types of cells - hepatocytes, cholangiocytes,
sinusoidal endothelial cells, macrophages, lymphocytes, dendritic cells and stellate cells,
arranged in a matrix, which allows them to work in co-ordination to synthesize,
metabolize and clear a wide range of molecules. The cells of the liver are supplied with
the various molecules by the flow of blood through a uniquely structured capillary
system. The sources of blood to the liver are the venous and the arterial blood, which
flow through the afferent and efferent blood vessels that interdigitate uniformly. This
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vasculature is unique because it is separated by a parenchymal mass of cells and at the
same time connected by small capillaries known as the sinusoids (1).
1.2.1 Hepatocytes
The hepatocytes are referred to as parenchymal cells and all the other cells types
are broadly termed non-parenchymal cells. The hepatocytes are large polyclonal cells,
numerous in number, constitute about 60% of the cells and 80% of the volume of the
liver. They are responsible for most of the metabolic and synthetic functions of the liver.
The hepatocytes are complex rhomboid shaped and have distinct surfaces for the different
functions they carry out. The area of the hepatocyte surface that faces the sinusoid is
greatly amplified and shaped into folds known as microvilli, which extend into the space
of Disse. Adjacent hepatocytes are held together to form long cords of cells by
intercellular adhesion complexes. The intercellular membrane has gap junctions for
transport of small molecules between adjacent cells. The intercellular membrane is
mostly flat, except at regions where it forms bile canaliculi. The bile canalicular
membrane is modified for the secretion of bile. The membrane facing the sinusoidal
lumen performs extraction of a wide variety of molecules from the blood and
simultaneous secretion of molecules synthesized by the hepatocytes (2). The nonparenchymal cells include stellate cells (HSC), Kupffer cells (KC) and liver sinusoidal
endothelial cells (LSEC).
1.2.2 Macrophages or Kupffer cells (KC)
These cells occupy about 2% of the liver. They are located within the sinusoidal
lumen, held closer to the LSEC by loose attachments. The KC express C3 and Fc
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receptors which clear large particulate material such as bacteria, worn out cells, dead
hepatocytes by phagocytosis. The KCs also clear immune complexes, tumor cells,
liposomes, lipid microspheres, iron and various other particulate matter. Clearance of
circulating endotoxin is one of the most important functions of KCs. Endotoxins activate
KCs and result in the secretion of interleukin-1/1 and tumor necrosis factor, reactive
oxygen species, and transforming growth factor-β (3-5).
1.2.3 Stellate cells (HSC)
The stellate cells (HSC) are located in the space of Disse between the hepatocytes
and the sinusoids and comprise 1.5% of the liver. Stellate cells store retinoids,
triglycerides, cholesterol and free fatty acids. HSC also secrete and degrade components
of the peri-sinusoidal matrix. During liver injury, these cells respond to inflammatory
cytokines such as IL-6 and TGF-β, become activated and acquire a myofibroblastic stage.
They undergo morphological changes, start proliferating and become contractile, lose
their lipid stores and secrete fibrogenic and inflammatory cytokines, which if left
unchecked, lead to fibrosis (6).
1.2.4 Sinusoidal endothelial cells (LSEC)
The liver sinusoidal endothelial cells (LSECs) comprise about 3% of the liver.
These cells are flattened and comprised of holes or fenestrations that are grouped together
to form sieve plates. The sinusoidal endothelium lacks a basement membrane, which
makes it unique from all other endothelial cells. LSECs are responsible for the clearance
of various molecules in the blood that flows through the sinusoids. They are also essential
components of the liver centered innate immune system, which also includes Kupffer
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cells, lymphocytes and dendritic cells (1). Since LSEC are the main focus of our study,
the functional aspects of this cell type are discussed in detail in the subsequent sections.
1.2.5 Cholangiocytes
The cholangiocytes are cells that line the bile ducts and form 1% of the liver
parenchyma. These cells are responsible for the modification of the canalicular bile
composition, which occurs through a series of secretory and absorptive processes (7, 8).
Cholangiocytes also interact with other liver cells such as hepatocytes, LSEC, HSC and
KC by releasing growth factors, peptides, nucleotides, pro-inflammatory and chemotactic
cytokines and other signaling molecules (7). These cells are involved in regulation of bile
formation, liver inflammatory processes, angiogenesis and fibrogenesis because of their
interaction with the other liver cells (8).
1.3 Organization of the liver
Hepatocytes are arranged in the form of cords through tight junctions that keep
them together. Vascular sinusoids are present on either side of the hepatocytes. The space
between the sinusoidal endothelium and hepatocytes is known as space of Disse. Stellate
cells are present in the space of Disse. The KCs are present in the sinusoidal lumen and
are loosely attached to the endothelial cells. The sinusoidal endothelium, because of its
position, is in interaction with all other cells of the liver and plays a crucial role in the
supply of required material to the hepatocytes and also in the scavenger and immune
systems of the liver (Fig. 1). Hepatocytes and other cells communicate by extending their
pseudopodia and microvilli through the fenestrations of the LSECs (Fig 2). Fenestrations
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permit the passive transport of solutes and regulate the traffic between blood and the
underlying hepatocytes (9).

Figure 1: Basic architecture of the liver. LSEC form the walls of the sinusoids and are
fenestrated. Stellate cells are found in the space of disse, whereas the Kuppfer cells are
found in the sinusoidal lumen. The lumen is lined on both sides by hepatocytes.
1.4 Structural and functional aspects of sinusoidal endothelial cells
Sinusoidal endothelial cells constitute the second most abundant cell type in the
liver. They are present between the hepatocytes and blood. The presence of sinusoidal
endothelial cells as a unique cell type was not discovered until the perfusion fixation and
electron microscopy studies by Wisse et al (10). Although LSEC populations contribute
to only 6.3% of the total liver volume, they represent approximately 40% of the total
number of hepatic cells (11).
1.4.1 Sieve function of the LSEC
LSEC have a unique morphological phenotype called the fenestrated endothelium.
The fenestrated endothelium is a subset of discontinuous endothelium, where the cells
have pores traversing the cytoplasm. Each pore is approximately 100 to 150 nm in
diameter. Macromolecules larger than 100nm-120nm in diameter or rigid molecules are
not allowed to diffuse through the fenestrae, attributing a sieve function to LSEC (12). In
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addition to the fenestrated endothelium, the cells also lack an organized basement
membrane. The paracrine secretions of the adjacent cells maintain the unique structure of
the endothelium. Hepatocytes and HSC secrete vascular endothelial growth factor
(VEGF), which stimulates LSEC to constitutively produce nitric oxide (NO) by
endogenous nitric oxide synthase (eNOS) (13). The LSEC maintains fenestrations for a
longer duration when exogenous VEGF is provided to the cell culture and VEGF induces
endothelial fenestrations in vitro (14).

Fig 2: Electron micrograph of sinusoidal endothelial cells, displaying the presence of
fenestrae clustered into sieve plates. The encircled region indicates a sieve plate and the
arrows point towards microvilli extending through the fenestrations.
LSECs lose their fenestrations in a process called capillarization or defenestration due to the formation and deposition of extracellular matrix and build up in
the space of Disse resulting in LSEC dysfunction. Deposition of collagen and laminin,
and thickening of the LSEC, characterizes defenestration (14). Defenestration precedes
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fibrosis and has been observed in various disease conditions such as primary biliary
cirrhosis (15), hepatitis (16), specific viral infection of the LSEC (17) and with the
venous administration of endotoxin (12, 18).
1.4.2 Functions of sinusoidal morphology
The LSEC fenestration allows chylomicrons and VLDL remnants to pass through
the sieve and allows access to the hepatocytes. Blood flow to the liver is a combination of
both arterial and venous blood. Normal arterial pO2 is 90-100 mm Hg and the pO2 for
portal vein is 45-55 mm Hg. As a result, tissue oxygenation of the liver is lower than that
for the other tissues (1). The presence of fenestrae optimizes the delivery of oxygen to the
hepatocyte. There are various studies that explore the role of fenestrae in various
conditions, such as liposomal transport (19), hydrodynamics (20), liver regeneration (21),
the role of VEGF regarding porosity (22), nitric oxide synthesis (23) and old age (24).
The fenestrae are important for the process of drug clearance. It allows the passage of
bound and unbound drugs to the space of Disse for uptake and clearance by the
hepatocytes (12).
1.4.3 Scavenger functions
The LSEC are the primary scavenger system of the liver. They contain numerous
coated pits on their surface which creates a cationic surface charge that allows for
endocytosis of negatively charged molecules. Different types of scavenger receptors such
as hyaluronan receptors, mannose macrophage receptors and Fc gamma receptors are
expressed by LSECs, which allow the removal of various macromolecules from the blood
such as proteins, polysaccharides, lipids and nucleic acids (25). The LSECs internalize
macromolecular waste such as extracellular matrix breakdown products (26), lysosomal
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enzymes (27), immune complexes (28), advanced glycation end products (29), acetylated
and oxidized low density lipoproteins (30)and modified proteins (31). There are recent
studies that suggest that LSECs might be involved in viral clearance
1.4.4 Stabilin receptors
This class of Type I multi-domain transmembrane receptors consists of two
proteins, Stabilin-1 and Stabilin-2. Stabilin-1 is expressed by LSECs in liver, spleen,
lymph nodes and alternatively activated macrophages (32).They both consist of multiple
EGF-like and fasciclin domains and a single X-link domain with amino acid sequences
that are 55% identical and 42% similar (Fig 3). The X-Link domain in Stabilin-1 is nonfunctional in that it does not bind hyaluronan. Stabilin-1 and Stabilin-2 have both
common and different ligand binding profiles. Stabilin-1 mediates endocytosis of
acetylated LDL (33), SPARC (Secreted protein acidic and rich in cysteine) (34),
Advanced glycation end products (AGE)(29), placental lactogen (35) and
phosphatidylserine (36, 37). Stabilin-1 functions as a bacteria-binding protein and
modulates angiogenesis (38). It helps in the lymphocyte migration and entry of
leukocytes to the site of inflammation (39).
Hyaluronic acid (HA) is a matrix polysaccharide with repeated disaccharide units
of D-glucuronic acid and N-acetyl glucosamine. HA is a major constituent of the ECM,
and serum HA is known to be associated with inﬂammation, wound healing, and
regenerative morphogenesis. Elimination of denatured or excess HA from the circulation
is necessary to maintain the normal range of blood viscosity (40). Stabilin-2 is
responsible for the efficient uptake of hyaluronic acid and degradation and functions to
regulate the amount of HA present in the body (26). In addition, Stabilin-2 receptors
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eliminate oxidized LDL and acetylated LDL (41), advanced glycation end products (29),
N terminal propeptides of types I and III procollagen (PINP and PIIINP) (31, 36),
phosphatidylserine(42) , chondroitin sulfates(43), and high and low molecular weight
heparins(44, 45) and small heparin oligos(46). In both rat and human, two isoforms of
HARE are present with molecular masses of 175 and 300 kDA or 190 and 315 kDa,
respectively. The isoforms are derived from the same precursor, which is the Stabilin-2
protein. Stabilin-2 is a large protein consisting of 2551 amino acids. The full length
315/300 kDa isoform is a type I membrane protein that contains a 2458 extracellular
domain which contains four cysteine rich/fasciclin like domains and a LINK domain
which binds to hyaluronic acid. The 190 kDa is similar to the C-terminal 1417 amino
acids of the 315 kDa and is derived by proteolytic cleavage by unknown mechanisms
(47). The clearance of HA by Stabilin-2 receptor has been used as a marker to determine
overall health of the liver (48, 49).

Fig 3: Stabilin receptors of the sinusoidal endothelial cells (36).
The mannose receptor is identical to the macrophage mannose receptor of the
Kupffer cells. It is responsible for the removal of waste collagen molecules and
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breakdown products that are degraded in the body by collagenolysis. This receptor
prevents the accumulation of gelatin, preventing conditions such as intravascular clotting.
These receptors facilitate calcium dependent clearance of glycoconjugates, which have
mannose residues at their terminus. The mannose receptor is involved in the uptake of the
lysosomal enzymes, tissue plasminogen activator and the carboxy-terminal properties of
type I procollagen (50). The Fc gamma receptor of the LSEC is similar to the receptors
on Kupffer cells. These receptors are involved in the receptor-mediated endocytosis of
immune complexes (51, 52).
1.4.5 Secretory functions
The release of prostanoids from KC and LSEC following exposure to endotoxin
triggers glycogenolysis in hepatocytes (53). The release of nitric oxide (NO) from LSEC
potentiates calcium signaling in surrounding hepatocytes (23). LSEC synthesize and
secrete fibronectin (54) and secretes endothelin, a potent vasoconstrictor, on exposure to
endotoxin treated Kupffer cells (55).
1.4.6 Sinusoidal dysfunction
The sinusoidal endothelial function is affected in various pathological conditions.
The fibrosis of liver is preceded by capillarization of the sinusoidal endothelium (56).
Capillarization promotes fibrosis as the capillarized LSECs activate the hepatic stellate
cells, which play an important role in the development of fibrotic liver (57). The
capillarization of LSEC also affects the delivery of oxygen to the hepatocytes and causes
hepatocyte hypoxia. The clearance of chylomicron remnants is affected by the size of
LSEC fenestrae. The normal function of the fenestrae prevents atherosclerosis due to
proper clearance of chylomicrons (58). Loss of endothelial fenestrae in liver cirrhosis
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may contribute to loss of hepatic function because of impaired exchange between
sinusoidal blood and hepatocytes. In aging animals, a process known as psuedocapillarization is observed with the thickening of the LSEC, marked reduction in size and
number of fenestrae and an incompletely formed basement membrane (59). In response
to injury, LSEC increase their production of cellular fibronectin (60).
1.5 Non-Alcoholic Fatty liver disease (NAFLD)
NAFLD is one of the rising health concerns in both the developing and developed
countries. It includes a spectrum of diseases ranging from simple infiltration of fat into
the liver tissues (steatosis) to cirrhosis and cancer. NAFLD is considered the hepatic
manifestation of metabolic syndrome, which includes type 2 diabetes mellitus,
hyperlipidemia, obesity and insulin resistance. The pathology of NAFLD is not clear.
Obesity and insulin resistance pose a high risk for development of NAFLD (61). NAFLD
begins as a simple deposition of fat in the hepatocytes. The accumulation of fat occurs
due to various early mechanisms. These include excessive intake of calories composed of
a variety of fats and carbohydrates, coupled with obesity (62), and excessive consumption
of high fructose foods/drinks, resulting in impaired lipid metabolism (63). There is an
increase in the export of fatty acids from adipose tissue and intestine to the liver. As the
amount of fatty acids imported by the liver is higher than the amount needed by it, the
excess results in an accumulation of triglycerides in the liver. Hyperinsulinemia causes
increased fat storage by the liver. Insulin resistance results in increased triglyceride
synthesis, fatty acid uptake and peripheral lipolysis resulting in fat accumulation in the
liver (64, 65). Uncontrolled steatosis coupled with the other risk factors proceeds to
fibrosis of the liver. In fibrotic conditions, the stellate cells are activated and attain a
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myofibroblastic stage. They secrete cytokines and extracellular matrix, resulting in the
augmentation of fibrosis. The fenestrae of the sinusoidal endothelium are lost and the
development of basement membrane occurs, resulting in capillarization of the sinusoidal
endothelium. The hepatocytes lose their microvilli and proceed to apoptosis. The Kupffer
cells are activated and secrete inflammatory cytokines (Fig 4). Sinusoidal endothelial
cells are known to maintain stellate cells in their dormant stage (66). Recent studies show
that LSEC dysfunction precedes inflammation and fibrosis in NAFLD (67), suggesting
that the LSEC might be responsible in initiating the fibrotic conditions. In NAFLD,
capillarization of sinusoidal endothelium has been observed (68) and serum HA levels
were found to be elevated (69). There is no known direct correlation between sinusoidal
dysfunction and NAFLD, which forms the focus of this study.

Fig 4: Cells in liver fibrosis and injury (70).
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CHAPTER 2

ISOLATION OF LIVER SINUSOIDAL ENDOTHELIAL CELLS.
(Note: This method described in this part has been published)
(Gopalakrishnan Sandhya and Edward N. Harris. "In vivo Liver Endocytosis Followed by
Purification of Liver Cells by Liver Perfusion." Journal of visualized experiments:
JoVE 57 (2011)).
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Chapter 2
Isolation of liver sinusoidal endothelial cells
2.1 Introduction
The liver is the metabolic center of the mammalian body and serves as a filter for
the blood. The basic architecture of the liver is majorly composed of hepatocytes (~ 80
%) and the remaining of the cellular mass is composed of Kupffer cells (KCs), stellate
cells (HSCs), and sinusoidal endothelial cells (LSECs). LSECs form the blood vessel
walls within the liver and contain specialized morphology called fenestrae. Fenestration
of the cytoplasm is the appearance of holes (~100 μm) within the cells so that the LSECs
act as a sieve in which most macromolecules, but not cells pass through to the
hepatocytes and HSCs. Due to the lack of a basement membrane, the gap between the
LSEC and hepatocytes form the space of Disse (71). HSCs occupy this space and play a
prominent role in regulation and response to injury, storage of retinoic acid and immunoregulation of the liver (72). LSEC are among the most endocytically active cells of the
body displaying an array of scavenger receptors on their cell surface. These include SRA, Stabilin-1 and Stabilin-2. Generally, small colloidal particles less than 230 nm and
macromolecules in buffer phase are taken up by LSEC, whereas large particles and
cellular debris are endocytosed (phagocytosed) by KCs (73). Thus, the bulk clearance of
extracellular material such as the glycosaminoglycans from blood is largely dependent on
the health and endocytic functions of LSEC. An increase in blood hyaluronan levels is
indicative of liver disease ranging from mild to more severe forms (74).
LSEC de-differentiate under standard culture conditions and must be used within
1 or 2 days upon isolation from the animal. With the exception of one report (75), there
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are no immortalized LSEC cell lines in existence. Even this immortalized cell line is dedifferentiated in that it does not express scavenger receptors that are present on primary
LSEC (our data, not shown). All cell biological studies must be performed on primary
cells obtained freshly from the animal. Differentiation of LSEC is marked by the
decreased expression of Stabilin-2 or HARE receptor, CD31, and the presence of
cytoplasmic fenestration (47). Differentiation of LSEC can be extended by the addition of
VEGF (76) in culture media or by culturing cells in hepatocyte conditioned medium (77).
The following protocol is adopted from (78, 79) with modifications (45, 80).
2.2 Materials and methods
2.2.1 Excision of liver
10 mL of 30% isoflourane in polyethylene glycol was added to a petri dish in a
closed 5.5 L chamber and allowed to equilibrate within the chamber. The rat was
anesthetized by placing it in the sealed chamber. Some cotton balls were put in a 30 mL
syringe tube and 2 mL of 30% isoflourane was added to it. The anesthetized rat was
placed on its back on a diaper-covered tray and the syringe tube was placed over the
snout. The entire abdominal cavity was exposed using bandage scissors and forceps. Two
strands of surgical silk or polyester thread (ligature) were drawn beneath the vena porta
immediately above the mesenteric branch using forceps. The forceps was withdrawn and
a loose overhand knot was tied. The vena porta was cannulated with an Insyte autoguard
catheter (18 GA, 1.3 x 300 mm, BD Biosciences). The needle was retracted by releasing
the spring-loaded trigger on the catheter. The overhand knot was tightened and secured
with another knot. The descending aorta (aorta abdominalis) was severed to allow blood
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to drain from the circulatory system. The liver was flushed with oxygenated tris buffered
saline (TBS, 154 mM NaCl, 10 mM trizma base salt, pH 7.4 ) at 37°C to remove the
blood at a flow rate of 20 mL/min. The liver turned from reddish purple to a loam color.
The liver was excised while being flushed by cutting away the GI tract and connective
tissue. The liver was placed on a plastic net over a funnel that allows buffers to be
collected and re-circulated and flushed for 10 min. The schematic of the perfusion
apparatus is illustrated in Fig 5.
2.2.2 Digestion of the liver by collagenase digestion
Freshly dissolved and filtered (0.45 μm) collagenase (100 mg/kg rat weight) was
added to 60 mL of Perfusion buffer 2 (67 mM NaCl, 6.7mM KCl, 4.8mM CaCl2.H2O, 10
mM HEPES,15% BSA, pH 7.4). The pump was stopped and the inlet tubing was
exchanged from the TBS flask to the collagenase solution. Immediately after flushing, the
digestion with collagenase was begun in a circulatory loop at a flow rate of 20 mL/min,
for up to 15 min. After flushing with collagenase, the pump was stopped, the catheter
was removed and the liver was transferred to a dish containing 20-30 mL of perfusion
buffer 1(142 mM NaCl, 6.7mM KCl, 10mM HEPES, 1.5% BSA, pH 7.4). The Glisson’s
capsule was peeled from the liver and the cells were shaken out in the liquid. As the
liquid becomes opaque with cellular material, the cells were transferred through a 100 μm
mesh, followed by filtration through a 30 μm mesh and then into a 50 mL conical tube on
ice. More Buffer 1 was added to the liver and cells were shaken from the liver matrix,
transferring the liquid to the mesh filters and conical tube. The above steps were repeated
until no more cells can be dislodged with reasonable shaking of the liver.
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Fig 5: Schematic of the perfusion apparatus. A) Set-up of apparatus during the
flushing/washing of the sinusoids of the liver, TBS is in a 1 L flask. B) A 125 mL flask
containing ~60 mL Buffer 2 with collagenase is used for digestion of the liver in a closed
circuit. The effluent line is also changed from the waste container to flask B through a
notch cut in the rubber stopper. The oxygen line is not submerged into the buffer
containing collagenase (flask B) to avoid foaming. The stoppers on each flask are
notched to allow efficient transfer of the effluent line and to prevent increased pressure
from the oxygen gas.

19
2.2.3 Hepatocyte and LSEC purification
The 50 mL conical tubes containing cells were centrifuged at 150 x g for 3 min to
pellet the hepatocytes. The liquid fraction containing non-parenchymal cells was
transferred to fresh 50 mL conical tubes on ice. The hepatocytes were washed by resuspending the pellet in perfusion buffer 3 (137mM NaCl,4.7mM KCl,0.7mM
MgSO4,1.2mM CaCl2.2H2O,10mM HEPES,1.5% BSA, pH 7.4) and the washes were
repeated two more times. At the end of the washes, the pellets were ≥97% pure
hepatocytes. The LSEC were obtained by centrifuging all of the tubes containing the
pooled supernatant (containing HSCs, LSEC, and KCs and some small hepatocytes) at
200x g for 10 min at 4°C. The buffer was aspirated and all the pellets were re-suspended
in a total of 35 mL RPMI/BSA (15g/L BSA in RPMI) at 4°C and centrifuged at 100 x g
for 3 min. The top 25 mL of liquid was collected and transferred to a clean 50 mL conical
tube. The pellet was re-suspended in the remaining 10 mL media and 25 mL of cold
RPMI/BSA was added and centrifuged at 100 x g for 3 min. The above steps were
repeated, and the cell pellet was discarded along with 10ml media. The supernatants were
centrifuged to pellet LSECs, KCs, and HSCs at 200 x g for 10 min at 4°C. Meanwhile,
percoll gradients were prepared by adding 20 mL 25% percoll in PBS on ice and then
underlaying with 15 mL 50% percoll in each tube.
The cell pellets were re-suspended in a total volume of 30 mL RPMI/BSA. Each
gradient was carefully overlaid with 10 mL of cells and centrifuged at 900 x g for 20 min
at 4°C. LSECs and KCs have very close buoyant densities and collect at the 25/50%
interface. HSCs are typically at the 25%/media interface due to their higher buoyancy as
lipid storing cells. Any remaining hepatocytes and blood cells have the lower buoyancies
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and are pelleted. The media and stellate cells were aspirated from the top down near the
25/50% interface and the cells in the 25/50% interface were collected and transferred to a
fresh conical tube with cold RPMI. The final volume was adjusted to ~40 mL to dilute
out the percoll. The conical tube was centrifuged at 350 x g for 10 min at 4°C to pellet
the cells. The cells were resuspended in ~10 mL pre-warmed RPMI at 370 C containing
100 U/mL penicillin, 100 µg/mL streptomycin and the cells were placed in an acidwashed glass-crystallizing dish. The cells were incubated for 15 min at 37°C in a tissue
culture incubator. The LSECs in the supernatant were collected from the dish by rocking.
The KCs adhere to the glass much more rapidly than LSECs. Alternatively, LSECs may
be separated from KCs by immunopurification using anti-CD31 or anti-Stabilin2/HARE
antibodies conjugated to magnetic beads. Viability and cell numbers were assessed by
trypan blue exclusion using a hemacytometer or with using an automated cell counter.
The LSECs were cultured on fibronectin-coated plastic dishes (Fig 6) at 37°C, 5% CO2,
RPMI/0.25% BSA with 40 ng/mL VEGF, 100 U/mL penicillin, 100 μg /mL streptomycin
or with hepatocyte conditioned media. The LSECs was assessed for internalization of
I125-HA.
2.3 Discussion
Anesthesia of the rat by the hanging drop method in which isoflourane vapor
induces unconsciousness is the preferred method for our studies. A vaporizer may also be
used instead of a syringe with cotton to maintain the animal outside the chamber, but the
surgical procedures are so quick, it is not required. Polyethylene glycol is added to the
isoflurane to decrease the vapor pressure and evaporation rate. Too much isoflurane
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vapor will induce death too quickly. If the animal dies before the liver is cannulated and
blanched with TBS, pooling blood may clot in the liver and prevent efficient washing of
the sinusoids and digestion with collagenase. Gey's buffered saline solution (GBSS) is
often substituted by other laboratories for the purification of LSECs. While it is useful for
LSEC purification, hepatocytes do not tolerate GBSS as well as Buffers 1-3 and
viabilities are not nearly as high. When measuring endocytosis, it is good practice to
measure background levels in the organ and in purified hepatocytes. This method is one
of two for efficient purification of LSECs following the liver perfusion with collagenase.
The other method separates the non-parenchymal cells by elutriation
centrifugation (81), instead of percoll gradient. The advantages for using elutriation over
percoll gradients are slightly higher cell viabilities and numbers. The downside is that
elutriation centrifugation requires a specialized rotor, dedicated centrifuge, and peristaltic
pump together which costs tens of thousands of dollars. This method only requires the
use of a refrigerated table-top centrifuge and peristaltic pump which is standard in many
laboratories. Separation of LSECs and KCs by selective adhesion is a standard method
(82, 83). While it is true that SECs will adhere to the glass and plastic, the key point is to
use acid-washed clean glass with no more than 15-minute incubation at 37°C at 5% CO2.
KCs will always adhere faster than LSECs and it is advisable to gently wash the KCs
with media to extract any remaining LSECs that have become loosely attached. Pronase
and other proteases are also omitted from the collagenase digestion steps in this protocol
to increase viabilities of the cells. Proteases digest extracellular receptors and may inhibit
cellular adhesion in the final purification steps. The method presented here has a wide
variety of applications. Perfusion of the liver for obtaining primary hepatocytes, KC,
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LSECs, and HSCs may be useful for a number of studies involving metabolic pathways,
immunoregulation, scavenger activities, and other physiological studies. The most
difficult part of this procedure is good cannulation, digestion of the liver, and handling of
the liver without having the catheter slip from the portal vein.

Fig 6: LSECs plated on fibronectin coated plastic 6-well dishes were incubated overnight
in RPMI supplemented with 0.1% BSA. Phase contrast images were taken at 100x
magnification.

CHAPTER 3
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Chapter 3
Effect of high fat diet on the liver

3.1 Introduction
The liver is central to the maintenance of energy balance as it regulates the supply
of glucose, ketone bodies, lipoprotein and triglycerides to peripheral tissues. Thus, it acts
as the primary processing center for the dietary derived lipids and glucose. The liver
stores excess glucose as glycogen and excess dietary-fatty acids and excess adipose
tissue-derived fatty acids in the form of triglycerides. In conditions of fasting or energy
insufficiency, the liver increases synthesis of very low-density lipoproteins (VLDL), βoxidation of fatty acids and ketogenesis. As the liver plays an important role in proper
metabolic handling of fatty acids, impairment of fatty acid storage in the liver due to
increased lipid intake poses as an important factor for the development of the metabolic
syndrome which includes insulin resistance, Type 2 diabetes, non-alcoholic fatty liver
disease (NAFLD), and cardiovascular disorders (84).
It has been observed that serum triglycerides, liver enzymes serum alanine
transaminase and alkaline phosphatase, cholesterol, serum HA are increased in NAFLD
(85). Fibrosis begins to develop in the liver due to high fat diet ingestion and NAFLD
(86). The following experiments were performed to evaluate the condition of the liver
and observe if fat accumulation has occurred and if fibrosis has initiated, in the livers of
the rats fed on high fat diet. Whole tissues were stained with H&E, Oil Red O and subject
to Coherent Anti-stokes Raman Scattering (CARS) microscopy. H& E is a combination
of two dyes, haematoxylin and eosin. Haematoxylin stains the acidic parts of the cell like
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the nucleus and nuclear material, whereas, eosin stains the basic components of the cell
such as proteins. This staining technique helps to visualize the morphology of the tissues.
Oil Red O is used to detect neutral lipids in the tissues. The staining is based on the
capability of the lipids to dissolve in the dye (87). CARS is a technique used to visualize
the lipids in tissues or individual cells. It is a label free imaging technique which is highly
sensitive and capable of visualizing lipid rich structures. CARS microscopy relies on the
intrinsic molecular vibration for contrast mechanism. It is particularly sensitive to the
lipid-rich structures due to the abundance of the CH 2 group and the distinctive CH 2
stretch-vibration frequency at 2840 cm- 1 (88).
3.2 Materials and methods
3.2.1Sample collection
Four week old Sprague-Dawley rats were maintained on standard diet (12%
energy from fat) or high fat diet (60% energy from fat) for 8 weeks. The diet was
manufactured by Testdiet and the composition of the diets is given in table 1. The weight
of the rats was measured every week. On the completion of the 8th week, the rats were
sacrificed and tissues harvested. The rats were fasted for 2 hours prior to sacrifice. The
cells of the liver were separated by the perfusion technique described in chapter 2. Blood
was collected from the aorta abdominalis during the surgical procedure. Plasma was
collected from blood and was stored at -800 C for later analyses. Liver, kidney, spleen, fat
pads tissues were stored at -200 C after adding RNAlater RNA stabilization reagent
(Qiagen) for future use.
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3.2.2 Biotinylation of advanced glycation end products (AGE)
Advanced glycated end-products (AGE) are the lipids or proteins that have been
glycated due to prolonged exposure to sugars (89). The AGE products in the serum are
biotinylated to prevent the reduction of these molecules and enable storage for longer
duration. 300 µL of plasma was immediately mixed with 300 µL of 10 mM biotin
hydrazide to a final concentration of 5 mM biotin hydrazide and the mixture was allowed
to react for 2 h at room temperature. After addition to the sample of an equal volume of
30 mM sodium cyanoborohydride in PBS, the mixture was stored in an ice bath for 45
min for promoting the reduction of the Schiff base formed in the hydrazide reaction. The
mixture was subjected to dialysis against PBS, to remove excess reagents (90). The
advanced glycation end products were collected for mass spectrometric analysis.
3.2.3 Histology of the liver
The liver tissues were fixed in 10% PBS-buffered formalin and subject to two
staining procedures: H&E staining and Oil Red O performed at the Veterinary Diagnostic
Center, UNL.
3.2.4 Blood chemistry
The liver profile was measured using Vetscan chemistry analyzer (Abaxis). The
VetScan Mammalian Liver Profile reagent rotor used with the VetScan Chemistry
Analyzer utilizes dry and liquid reagents to provide veterinary in vitro quantitative
determinations of alanine aminotransferase (ALT), albumin (ALB), alkaline phosphatase
(ALP), bile acids (BA), total bilirubin (TBIL), total cholesterol (CHOL), gamma
glutamyl transferase (GGT), and (blood) urea nitrogen (BUN) in heparinized whole
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blood, heparinized plasma, or serum (Abaxis vetscan protocol). Heparinized whole blood
was used for the analysis. Triglyceride levels in the serum were measured using a
triglyceride assay kit (Cayman Chemical) according to the manufacturer's instructions.
Free fatty acids were measured using Bioassay systems Enzychrom free fatty acid assay
kit.
3.2.5 Thin layer chromatography of lipids
Liver tissues of control and HFD rats were frozen at -800 C immediately after
excision. They were thawed on ice on the day of the experiment for use. Fifty mg of liver
tissue was weighed and used for lipid extraction. The tissue was homogenized in 3 mL of
chloroform: methanol (2:1) solution containing 0.05% BHT (butylated hydroxy toluene).
The homogenate was transferred to a glass tube and shaken at room temperature for 1 hr.
Then it was centrifuged at 2500 rpm for 10 min. The supernatant was collected and 2 mL
of 0.9% KCl was added and mixed well by vortexing. It was set aside for ~ 20 min until a
phase separation was seen. The upper phase was carefully aspirated. The lower phase was
transferred to another tube and centrifuged for 5 min at 2000 rpm. The pellet was
obtained and resuspended in chloroform. The sample tubes were sealed under argon gas
for longer storage periods to avoid lipid peroxidation. The samples along with
triglyceride and cholesteryl ester standards were loaded on K5 20 X 20 TLC plates using
a TLC spotter. The solvent system used was Hexane: Ether: Acetic acid (8:2:0.1). The
bands were developed by placing the TLC plate in iodine vapor saturated container. The
intensity of the bands was measured using densitometry by ImageJ.
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3.3 Results
The weight gain of the HFD rats and control rats over the period of 8 weeks and
was not significantly different (Fig 7). The visual examination of the livers from the
control and HFD rats revealed a distinct morphological difference. The livers of the HFD
rats look mottled and yellowish in color compared to the control (Fig 8). The livers of the
HFD rats show increased lipid accumulation compared to the livers of the control rats, as
evidenced by the H& E staining and Oil Red O staining (Fig 9). Huge lipid droplets were
observed in the livers of HFD rats compared to the control rats, by CARS imaging (Fig
9).
Though there are various studies that indicate that there is an increase in serum
triglyceride and serum cholesterol in NAFLD (91), our experiments showed that the
serum triglyceride, serum cholesterol of the HFD rats were not significantly different
from the control rats (Fig 10) suggesting transport systems for fatty acids is not impaired.
We observed an increase in serum alkaline phosphatase levels in the HFD rats, whereas
the levels of serum ALT were not significantly different (Fig 11). Though a significant
difference in serum triglyceride was not observed, thin layer chromatography of the lipids
isolated from the livers of the control and HFD rats reveals that there is an accumulation
of triglyceride and cholesteryl ester in the livers of the HFD rats (Fig 13). Densitometry
measurements show a statistically significant difference in the accumulation of
triglycerides and cholesteryl ester in the HFD livers compared to the control (Fig 14).
The serum of the HFD rats shows an increased free fatty acid content (Fig 12), though the
difference is not statistically significant due to low sampling number (n=4).
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3.4 Discussion
The ingestion of high fat food by the rats for a period of 8 weeks has resulted in
significant changes in their livers compared with the rats maintained on control diet. The
liver shows significant damage and is in the initial stages of fibrosis. They show an
increased accumulation of lipid, especially triglycerides and cholesteryl ester. Though
there is no significant change in liver enzyme, ALT, serum triglyceride and serum
cholesterol values, there is a significant increase in serum ALP, which is indication of
liver damage and injury. An increase of serum free fatty acid could be observed in the
HFD rats, which indicates the increased lipolysis observed in insulin resistance. All these
experiments show that this diet was a successful model for initiating lipid accumulation
and resulting in NAFLD in the rats.
Though there are various studies about the increase of serum triglycerides,
cholesterol and aminotrasferases in non-alcoholic fatty liver disease (61, 84). The levels
of serum alkaline phosphatase alone is elevated in our observations. It is concurrent with
observations of another study where only the elevation of serum alkaline phosphatase
levels are observed (92). Alkaline phosphatase levels are generally increased in
conditions of biliary obstruction (93). The relation between sinusoidal endothelial
dysfunction and biliary obstruction is an interesting aspect to investigate.
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Table 1: Composition of standard diet.
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Table 2: Composition of high fat diet

32

Fig 7: Weight: Four week old Sprague-Dawley rats were fed either control (black bars) or
high fat (red bars) diets. Weight gain was measured weekly. n= 10
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Table 3: Blood chemistry
Parameter
Weight (gms)
Albumin (g/dL)
ALP (U/L)
ALT (U/L)
BUN (mg/dL)
Serum cholesterol(mg/dL)
Serum
triglyceride(mg/dL)
Serum HA
Serum bile acids (umol/L)
Food consumed (Kcal)
Serum free fatty acids
(µmol/L)

Control
320 ± 6.899
4.3 ± 0.118
167± 18
36 ± 2.3
15±0.7
95.6±7.7
91.2±11.8

High fat
354 ± 8.5
4 ± 0.0886
358 ± 25
40 ± 1.7
16±0.9
112 ±4.3
67.1± 7.6

P value
0.005
0.032
≤ 0.001
0.226
0.474
0.073
0.103

27.3±3.4
14.6 ± 4.9
50,712
153.75± 22.8

41.5±4.5
13.2±2.7
57,440
229±44

0.02
0.793
0.182
n=4
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A

B

Fig. 8: Abdominal exposure and visual inspection of livers of rats fed (A) control and
(B) high-fat diets. Increased fat deposition in the liver was often visible while the liver
was extracted from an anesthetized live animal.
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Fig 9: Liver tissues were sliced and then stained with H&E, or Oil Red O. Tissues slices
were also subject to CARS microscopy to identify/confirm presence of fat droplets.
Yellow arrows = nuclei stained with DAPI, Red Arrows = fat droplets.
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a

b

Control

High fat

Control

High fat

Fig 10: Blood chemistry a) Serum cholesterol levels, n= 10, p = 0.073, by t-test b) Serum
triglyceride levels. n= 10, p = 0.103 , by t-test. Black bars are control rats and red bars
indicate high fat rats.
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a

b

Control

High fat

Control

High fat

Fig 11: Liver enzymes values in control and high fat rats a) Alanine transaminase. n=1 0,
p= 0.226 by t-test
b) Alkaline phosphatase levels. n= 10, p ≤ 0.001, Black bars are control rats and red bars
are high fat rats.
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Fig 12: Serum free fatty acid assay. n = 4, p =0.182(t-test).
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Fig 13: Lipid composition of liver tissue by Thin Layer Chromatography (TLC). Liver
tissues (50 mg) from 5 rats in each group were processed for lipid content and prepared
for TLC. Samples were spotted at the origins (arrows) and allowed to migrate up in a
solvent (hexane, diethyl ether, acetic acid) saturated atmosphere. Plates were then
stained with iodine vapor. Control 1L11,1R12,2L13,2L16,2L18 and High fat 1LL, 2RO,
P, 1LQ and 2LS are the names of the control and high fat rats analyzed.
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A

B

Fig. 14: Densitometry of TLC data. A) Triglyceride levels in liver. n=5, p=0.015 (t-test),
b) Cholesteryl ester levels in liver . n= 5, p =0.007 Bands/spots of each control and HF
groups were analyzed by ImageJ software and quantified.
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CHAPTER 4

SINUSOIDAL ENDOTHELIAL DYSFUNCTION IN FATTY LIVER DISEASE

42
Chapter 4
Sinusoidal dysfunction in fatty liver disease
4.1 Introduction
Sinusoidal endothelial dysfunction in the liver is marked by capillarization or
defenestration, which is defined as the loss of fenestrae and the development of basement
membrane (58). The LSEC dysfunction results in decreased endocytic capability (94).
Recent studies reveal the involvement of LSEC dysfunction in NAFLD. Sinusoidal
endothelial cells are subject to insulin resistance in fatty liver disease. It has also been
observed that sinusoidal endothelial dysfunction precedes inflammation and fibrosis in
fatty liver disease (40, 67, 95). Currently, there are no studies that elucidate the role of the
endocytic function of the LSECs in fatty liver disease.
Hyaluronic acid (HA) is a matrix polysaccharide with repeated disaccharide units
of D-glucuronic acid and N-acetylglucosamine. HA is a major constituent of the ECM,
and serum HA is known to be associated with inﬂammation, wound healing, and
regenerative morphogenesis. Elimination of denatured or excess HA from the circulation
is necessary to maintain the normal range of blood viscosity (96). Though many studies
show the elevation of serum HA in NAFLD, the reason behind the elevation has been
unexplained.
In our current study, the liver tissues were subjected to scanning electron
microscopy to reveal the structural changes in the fenestrae. The isolated hepatocytes and
LSEC were stained with Oil Red O, BODIPY stains and CARS microscopy was
performed to observe the lipid accumulation in the cells. Serum HA was measured in the
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control and HFD rats. LSECs isolated from control and HFD livers were plated on
fibronectin-coated wells and assayed for 125I-HA endocytosis. RNA isolated from the
LSEC of the control and HFD rats were analyzed by micro-array analysis to study the
expression of different genes in the LSEC.
4.2 Materials and methods
4.2.1 SEM of the liver
The rat was anesthetized and the procedure detailed in chapter 2 was followed
until after the cannulation of the liver with a catheter. The liver was then flushed with
TBS and perfused with fixation buffer (3% glutaraldehyde, 2.5% paraformaldehyde,
2mmol/L calcium chloride, 2% sucrose and 0.1 mol/L cacodylate buffer) at a constant
perfusion rate of 10 mL/min for 10 minutes (97). The tissue is then isolated from the
animal and cut into thin slices with a clean razor blade and stored in fixation buffer. The
fixed tissues were then processed by the Microscopy Core Facility at UNL for scanning
electron microscopy (SEM).
4.2.2 Staining of cells
The isolation of the cells of the liver was performed as described in chapter 2. The
isolated hepatocytes and sinusoidal endothelial cells were stained with Oil Red O and
BODIPY. CARS imaging was performed to visualize the lipid content in the cells. Oil
Red O staining was performed in the following manner. The isolated hepatocytes were
cultured in DMEM with 8% FBS and sinusoidal endothelial cells were cultured in RPMI
containing 0.5% BSA for at least one hour. Media was removed from cultured plates,
plates were rinsed with 5 mL phosphate buffered saline (PBS), and the cells were fixed
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with 5 mL 4% buffered formalin for 15 min at room temperature. After 10 min, the
formalin was discarded and fresh formalin was added and incubated for at least 1 hr,
followed by 2 rinses with sterile water and subsequent 5 min incubation with 60%
isopropanol. The isopropanol was removed and the cells were stained for 10 min with 5
ml of freshly diluted and filtered working Oil Red O solution (Working solution is 6 parts
Oil Red O stock solution and 4 parts water). Oil red O stock solution is 0.35% oil red in
100% isopropanol. The stain was then removed and the cells were washed 5 times with
sterile water. Images of cells stained with Oil Red O were obtained with a phase contrast
microscope (98, 99).
The fluorophore BODIPY specifically stains neutral lipids. BODIPY staining was
performed following the procedure as described previously (100). The cells were cultured
on fibronectin-coated plastic chamber slides. They were rinsed with Dulbecco’s
phosphate buffered saline, fixed for 20 min with formaldehyde containing buffer (0.1 M
PIPES pH 6.9, 1 mM EGTA, 3 mM MgSO4, 2.5% formaldehyde) and washed 3 times for
10 min with D-PBS before a short permeabilization with D-PBS + 0.1% triton X-100.
The cells were washed with D-PBS following permeabilization and BODIPY was added
on to the coverslips and incubated for 30 min. A 1 mg/mL BODIPY stock solution
dissolved in DMSO was then diluted to 0.1 mg/ml and added to the cells. The slides were
washed three times with D-PBS for 10 min each. Finally, coverslips were mounted using
the UltraCruz mounting media. The cells were then observed under a fluorescent
microscope (100).
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4.2.3 CARS imaging
The isolated hepatocytes and LSEC were cultured on fibronectin-coated chamber
slides for two hours and then fixed with 4% buffered formalin. The cells were visualized
using CARS imaging at 2845 cm-1 with the assistance of Mr.Xiangnan He under the
direction of Dr. Yongfeng Lu, Professor of Electrical Engineering at the University of
Nebraska.
4.2.4 Measurement of serum Hyaluronate (HA)
The levels of HA in the serum from control and HFD rats were measured by
ELISA using the Quantikine ELISA HA assay kit. The kit employs a solid phase ELISA
to measure ≥ 35 kDa HA. It is a quantitative sandwich immunoassay method. The kit
supplies a microplate onto which recombinant human (rh) Aggrecan, an HA binding
protein has been pre-coated. Standards, controls, and samples were pipetted into the wells
and any Hyaluronan present was bound by the immobilized rhAggrecan. After washing
away any unbound substances, enzyme-linked rhAggrecan was added to the wells. It was
followed by a wash to remove any unbound rhAggrecan-enzyme reagent and a substrate
solution was added to the wells. The color development was stopped and measured. The
intensity of color developed is in proportion to the amount of Hyaluronan bound in the
initial step (Quantikine ELISA HA assay).
4.2.5 In vitro endocytosis of125I-HA
The isolated sinusoidal endothelial cells were cultured on fibronectin-coated 12well plates in RPMI containing 0.05% BSA and allowed to recover for at least 90 min.
Meanwhile two sets of endocytosis media (DMEM+0.05% BSA) containing 1) 1µg/ml
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125

I-HA (hot) and 2) 1µg/mL 125I -HA+ 100 µg/mL unlabeled HA (hot +cold) was

prepared. After the cells are recovered, RPMI media was aspirated and the media
containing either hot or hot+cold HA was added to the cells. The internalization of
hot+cold HA by the cells served as a control to measure the specificity of HA uptake.
The cells were allowed to internalize 125I-HA for a period of 3 hours followed by three
washes with HBSS (Hanks Buffered Salt Solution) and harvested using 0.5% NP-40. The
radioactivity of the cell lysates was measured by gamma counter. The amount of
radioactivity measured is proportional to the amount of 125I-HA taken up by the cells. The
protein content of the lysates was measured using Coomassie blue Bradford protein assay
and the amount of 125I- HA uptake is measured as CPM/mg protein (counts per
minute/milligram protein).
4.2.6 Western blot of the LSEC lysates
The cells were lysed with 0.5% NP-40 containing protease inhibitors such as
EDTA and PMSF. The lysates were spun briefly to settle any cell debris and the protein
concentrations were measured using Coomassie blue Bradford protein assay method.
Equal amounts of protein from the lysates was loaded on a 5% acrylamide gel and
transferred to a nitrocellulose membrane after SDS-PAGE. The membrane was probed
with anti-rat Stabilin-2 (Ab30) antibody and detected with anti-mouse antibody
conjugated to horse radish peroxidase.
4.2.7 RNA isolation and microarray analysis
The isolated sinusoidal endothelial cells from replicates of control and HFD rats
were stored in RNALater until utilized for RNA purification. RNA was isolated from the
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replicates using the Trizol reagent (Life Technologies) followed by additional cleaning
using an RNeasy kit (Qiagen). Microarray analysis was performed using Affymetrix Rat
1.0 gene chips at the Center for Bioinformatics and Systems Biology, University of
Nebraska Medical Center, Omaha. The microarray results were used to identify potential
genes that are either up- or down-regulated in the high fat diet regimen.
4.2.8 Analysis of Stab-2 gene expression by qPCR
RNA isolated from control and HFD rats were used for qPCR analysis of the
difference in Stab-2 gene expression. Two different sets of primer pairs , 1) Stab-2 2771
For 5'-GAGGAAACGGGATTGACTGTGAACCCAT-3' and Stab-2 3590 rev 5'ATGCCGTTATGCAAGTCATTCTTCAGGAG-3' , 2) Stab-2 3343 For 5'TCTTTACCAAGTCTACTCACCCGTCTG-3' and Stab-2 Stab-2 3590 rev 5'ATGCCGTTATGCAAGTCATTCTTCAGGAG-3' were used. cDNA synthesis was
performed using Revertaid first strand cDNA synthesis kit(Fermentas). qPCR was
performed using iTaq Universal SYBR Green Supermix (Biorad). The samples were run
on ABI 7500 (Applied Biosystems) on the standard protocol. GAPDH gene was used for
the reference gene expression. The change in expression was calculated using the ΔΔCt
method.
4.3 Results
Staining of isolated hepatocytes from control and HFD rats showed considerable
accumulation of fat in the hepatocytes in HFD rats as compared to the control (Fig 15).
Staining of isolated sinusoidal endothelial cells reveals that these cells do not accumulate
fats irrespective of the diet ingested (Fig 15). The scanning electron micrograph of the
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liver tissue from the control and the HFD rats are not very different, though the
fenestrations seems to be more disorganized in the HFD rats compared to the control (Fig
16). Serum HA is elevated in the HFD rats (Fig 17). The in vitro endocytosis of I-HA
experiments show that the uptake of
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I-HA is impaired in sinusoidal endothelial cells of

the control rats compared to the HFD rats (Fig 18). The western blot of the lysates of the
isolated LSEC culture of control and HFD rats show that the protein expression of Stab2
remains the same in both control and HFD rats (Fig 19). Densitometry measurements
show that the amount of protein expressed is not significantly different through the
microarray data show a downward trend (Table 4). qPCR analysis of Stab2 gene
expression shows that there is 42 % decrease in expression in HFD rat livers compared to
the control rats (Fig 20). A preliminary list of the genes revealed by microarray analysis
to be up-regulated or down-regulated by the high fat diet is given (Table 3 and table 4).
Different inflammatory response genes such as IL-6, Ccr1, Orm1, Vnn1, Olr1 and Ccl12
are upregulated, suggesting the role of stabilin-2 in inflammatory response to the high fat
even before the fibrosis is set in. Other genes that are upregulated are Lbp, Ugt2b, Lox,
Kng1, St8sia3, Lipc and LOC498793. Stabilin-1 and stabilin-2 are down regulated, but
not to a significant level. qPCR analysis of the gene expression is required to give the
exact fold change between the control and HFD rats.
4.4 Discussion
NAFLD is the major predictor for more serious health problems such as metabolic
syndrome, hepatitis and cirrhosis. The sedentary lifestyle, in addition with the increased
consumption of refined foods rich in fats and fructose is likely the reason for the
proliferation of this disorder. It has been observed that a decrease in the consumption of
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fatty refined foods and an increase in physical activity fully reverses NAFLD to normal
healthy tissue (101). Though there are various studies that elucidate the effect of this
metabolic disorder on the cells of the liver, the development of the disease is still very
vague and requires more study. SEM of the liver reveals a change in the morphology of
the fenestrae in the livers of the HFD rats. A decrease of the endocytic capability of the
LSECs suggests that these cells are adversely affected during early stages of NAFLD.
The staining of the isolated LSEC and hepatocyte helped identify that LSEC do not
accumulate any fats suggesting that the direct effects of stored fatty acids (triglycerides)
do not affect LSEC endocytosis directly, but that the effects of lipotoxicity may be in
play.
The microarray results reveal certain genes of interest that are upregulated.
Different inflammatory response genes such as IL-6, Ccr1, Orm1, Vnn1, Olr1 and Ccl12
are upregulated, suggesting the role of LSEC in inflammatory response to the high fat
even before the fibrosis is set in. IL-6 is an interleukin and the circulating levels and
expression of IL-6 is often found elevated in fatty liver disease (102). Ccl12 is a
chemokine and is similar to Ccl2 and it is usually elevated along with other cytokines in
NAFLD (103). Orm1 encodes for alpha-1 acid glycoprotein, also known as orosomucoid
1, whose expression is elevated as an acute immune response, has been observed to
increase in hepatic steatosis (104).Vnn1 is an inflammatory response protein, which has
been studied to be upregulated in fatty liver disease (105). Olr1 exhibits the activity of
oxidized lipoprotein receptor, and is elevated as an inflammatory response. Though there
is no literature pertaining to increased expression in NAFLD, Olr1 has been studied in
relation to myocardial infarction (106). Other genes that are upregulated are Lbp, Ugt2b,
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Lox, Kng1, St8sia3 and Lipc. Ugt2b belongs to the family of UDP-glucoronyl
transferases, a group of enzymes involved in glucoronidation of toxic substances and aids
in their removal. Drug metabolic alterations have been observed in NAFLD (107) and a
study of the elevation of Ugt2b gene will provide a deeper understanding of the process
in NAFLD. Lbp is lipopolysaccharide-binding protein and is found to be elevated in
response to circulating endotoxin (108). Lox is lysyl oxidase and has been studied for its
role in collagen fibril formation and fibrogenesis (109) and is being implicated as one of
the genes in fatty liver disease in relation to fibrogenesis (110). Kng1 has been implicated
in a positive role for endothelial cell proliferation and has been found to be one of the
genes routinely over expressed in NAFLD (111). St8sia3 encodes for a protein involved
in glycosphingolipid pathway and protein glycosylation (112). The relation between over
expression of this gene and NAFLD has not yet been studied. Lipc encodes hepatic
triglyceride lipase and has been studied in association with diabetes mellitus (113), but no
relevant studies in relation to NAFLD have been carried out. Scd1 encodes for stearoylcoA desaturase, which is a key enzymes in the synthesis of unsaturated fatty acid chains.
There are various studies reporting the increase in expression of Scd1 in the livers in fatty
liver disease (114-116), though we have observed that the expression of Scd1 is down
regulated in LSEC. An in-depth analysis of genes in other lipid metabolic pathways is
required to understand the downward trend in expression of Scd1 observed in LSEC. We
observed that expression of stabilin-1 and stabilin-2 are down-regulated as seen by
microarray analysis, and stab2 gene expression is decreased by 42 % as validated by
qPCR.
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Elevated serum HA levels are in agreement with the decreased LSEC endocytosis
rate, while receptor levels are unchanged indicating that endocytic machinery for receptor
internalization may be impaired.

These studies along with the investigation of what

LSEC genes are affected by the high fat diet open avenues for understanding the role of
LSEC in early events of NAFLD.
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Fig 15: Isolated hepatocytes and LSEC as viewed by either BODIPY staining, Oil Red O
staining, or Coherent Anti-Stokes Raman Scattering (CARS) Microscopy. BODIPY
stains fat droplets in the fluorescent green wavelength (Ex 495:Em 519), Oil Red O stains
fat droplets red under PC light microscopy, and CARS microscopy at 2845 cm-1 for CH2
symmetric stretching vibration. Yellow arrow shows distinction of a single hepatocyte in
a large group of LSEC stained with Oil Red O. SEC do NOT store fats
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Fig 16: SEM micrographs of livers from rats fed control (A-D) and HF diets (E-H).
Fenestration (yellow arrows) in the LSEC of both groups is in good condition although a
little more disorganized in the HF group. The green arrows point to adjacent hepatocytes
between the sinusoidal vessels and the red arrows show fat droplets that originated in the
hepatocytes. The spherical shapes in G and H are displaced lipid droplets.
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Fig 17: Serum HA levels were measured from both control and HFD rats using the
Quantikine ELISA HA assay kit (R &D systems). Each data point represents an animal
with the red bars indicating the mean, n=9, p = 0.02 by t-test.
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Fig 18: In vitro endocytosis; LSEC isolated from control and HFD livers were plated on
fibronectin-coated plate, recovered for 2 hours and then allowed to internalize 125I-HA for
3 hours. Cells were then washed and measured for radioactivity and protein levels. n=4,
p= 0.018, by t-test.

Control rats

High fat rats

Fig 19: Western blot of LSEC lysates from control and HFD rats. The proteins were
probed with Stabilin-2 antibody (Ab30). The two arrows correspond to the two isoforms
of stabilin-2 protein (300 and 170 kd). The black boxes indicate the marker of 250 kd.
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Table 4 Summary list of genes upregulated
Gene

High fat

Function

/Control
IL-6

1.86

Interleukin

Ccr1

1.79

Chemokine receptor

Orm1

2.7

Orosomucoid 1

Vnn1

2.1

Vanin 1

Olr1

1.99

Oxidative low density lipoprotein receptor 1

Ccl12

2.03

Cytokine

Lbp

2.17

Lipopolysachcharide binding protein

Ugt2b

2.84

UDP-glucoronyl transferase family

Lox

2.83

Lysyl oxidase

Kng1

2.56

Kininogen 1

St8sia3

2.27

alpha2-8 sialyltransferase.

Lipc

1.93

Hepatic lipase

Table 5 Summary list of genes down regulated
Gene

High fat/Control

Function

Scd1

0.3

Stearoyl CoA desaturase.

Stabilin-1

0.65

Scavenger receptor

Stabilin-2

0.66

Scavenger receptor
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Control

High fat

Fig 20: qPCR analysis of Stab-2 gene expression. n= 3, p≤ 0.001(t-test).
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CHAPTER 5

CONCLUSIONS AND FUTURE DIRECTIONS

Chapter 5
Conclusions and Future Directions
The pathogenesis of NAFLD is not yet clear and there is an on-going search for
specific serum markers that help diagnose NAFLD. Though there are various research
studies to elucidate the effect of fatty liver on the different cells of the liver, sufficient
research into the role of liver sinusoidal endothelial cells (LSEC) in the pathogenesis of
the disease has not been done. The LSEC act as a liver sieve by allowing macromolecules
and chylomicrons to traverse through their fenestrations (sieve plates) to hepatocytes
(58). Since LSEC regulate serum-derived macromolecular exposure to hepatocytes, we
asked what role LSECs play in the pathogenesis of NAFLD. Two sets of rats were
maintained on standard and high fat diets (HFD) respectively for a period of 8 weeks.
The lipid accumulation in the rat livers, isolated hepatocytes and LSEC were visualized
by Oil Red O, BODIPY and CARS imaging. These analyses reveal the accumulation of
lipid droplets in the hepatocytes of HFD fed rats in contrast to the LSECs. These studies
reveal that the LSEC do not accumulate fat due to the high fat diet and do not respond to
the diet in a similar fashion as the hepatocytes. We carried out in vitro endocytosis of
125

I-HA that showed 125I-HA uptake is significantly higher in isolated SEC of control rats

compared to HFD fed rats, as measured by statistical analyses using t-test. We also
observed that serum hyaluronate (HA) levels and alkaline phosphatase (ALP) levels were
increased in HFD fed rats, in contrast to alanine transaminase (ALT), triglycerides and
cholesterol, which remained the same. Though the fasting serum triglyceride levels of the
HFD were not significantly different from the control rats, thin layer chromatography of
the lipid extracts of the liver tissues from the HFD and control rats showed a significantly
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higher amount of triglycerides and cholesteryl ester in the HFD rats compared to the
control rats, as measured by statistical analyses using t-test. All these experiments
established that the rats fed on HFD were suffering from fatty liver disease after 8 weeks
of high fat food consumption.
The most significant observation of the study so far has been the decreased
uptake of hyaluronate (HA) by the isolated SEC. Serum HA is also significantly high in
the HFD rats compared to the control. Serum HA has also been observed to be elevated
in various diseased conditions including diabetes mellitus (117), liver hepatitis and
cirrhosis (118) and hepato-cellular carcinoma (119), but the reason for the elevated
serum HA in these conditions has not been elucidated.
The Stabilin-2 receptor is the only receptor on the SEC that is responsible for the
clearance of HA (26) and other matrix material. The decrease in uptake of HA in the
livers of HFD rats suggests the impairment of protein function, which could be either due
to the decreased production of the protein, the decreased expression of the stabilin-2 gene
or a malfunction in the endocytic pathway. The Stabilin-2 protein expression was
measured by performing a western blot using the isolated LSEC culture lysates. The
study revealed that there is no difference in the protein expression between the control
and HFD rats. RNA was isolated from the LSECs of the control and HFD rats and
subjected to microarray analysis, which revealed that the stabilin-2 gene expression was
not changed between the control and HFD rats. Post-translational modification of
stabilin-2 might be a reason for its decreased endocytic capability in the HFD fed rats.
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Insulin resistance plays a role in the pathogenesis of liver damage in fatty liver
disease (120). Some studies also suggest that both of them have a common pathogenic
mechanism (121). Insulin resistance and hyper glycemic conditions results in activation
of four pathways, the Protein Kinase C/Diacyl Glycerol pathway (PKC/DAG), the
sorbitol pathway, the hexosamine pathway and the formation of advanced glycation end
products (AGE) (122). The hexosamine pathway results in the channeling of fructose-6phosphate to GlcNAC (N-Acetyl glucosamine). The increased production of GlcNAC
results in post translation attachment of O-GlcNAC to serine and threonine residues of
proteins, resulting in their inactivation (123). As there is an evidence that serine-2497 on
the cytoplasmic side of the Stab-2 protein is phosphorylated and activated by
phosphorylation (unpublished data), it will be interesting to see if the protein undergoes
post translational O-GlcNAC attachment due to hyperglycemia and insulin resistance.
Insulin promotes nitric oxide (NO) production through the activation of the
PI3K/Akt/endothelial nitric oxide synthase (eNOS) signaling pathway. The
phosphorylation of eNOS at Serine 1179 results in vasodilatation and vascular protection.
When insulin resistance develops, the PI3K pathway is inhibited and the PKC/DAG
pathway is initiated. The PKC/DAG pathway is known to decrease eNOS activity (124).
Hyperglycemia also results in mitochondrial dysfunction, which results in increased
superoxide production (125). The superoxides result in the production of reactive
peroxynitrite species which uncouple and inactivate eNOS by binding to
tetrahydrobiopterin which is an essential cofactor for eNOS activity, resulting in
production of more reactive species instead of NO (126). Hepatocytes have been shown
to increase the production of inducible nitric oxide synthase (iNOS) as an inflammatory
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response due to high fat diet. iNOS is known to cause insulin resistance by Snitrosylation of the insulin signaling proteins (126).
The response of the LSEC to hyperglycemic conditions is still being studied.
LSEC undergo insulin resistance due to hyperglycemic conditions in fatty liver disease
and it precedes fibrosis and inflammation. This study is based on the decrease of Akt
phosphorylation and eNOS in the liver, in vivo hemodynamic studies and decrease in
vasodilatation (95). Another study by the same group suggests that iNOS production is
increased in the hepatocytes due to high fat diet, which induces insulin resistance in
sinusoidal endothelial cells, measured by in situ liver perfusion and hemodynamic
studies. It is not clear how isolated LSECs respond (67). In steatosis, it has also been
observed that the sinusoidal narrowing takes place and there is a decrease in sinusoidal
flow (127). In situ assessment reveals an increase in portal pressure and intra hepatic
resistance due to impaired sinusoidal endothelial function. An increase in
vasoconstrictors and morphological disorganization was observed which precedes
inflammation and fibrosis (128).
It will be beneficial to study the effect of insulin on the isolated LSEC, by
exposing it to insulin and performing a pathway array analysis to study which proteins
are being activated/deactivated due to insulin exposure in both control and HFD rat
LSEC. The study of the changes in gene expression in the proteins in the insulin signaling
pathway by qPCR will reveal the changes in the gene expression in the cells due to
hyperglycemia and insulin resistance. Potential candidate genes are the class of Insulin
receptors, eNOS, O-GlcNAC transferase, and inflammatory cytokines such as IL-6, TNF
and TGF-β. The effect of insulin resistance needs to be observed in isolated LSEC,
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paying special attention to the hexosamine pathway and the production of O-GlcNAC.
Mass spectrometric studies of the Stabilin-2 protein will reveal if there is a post
translation attachment of O-GlcNAC due to insulin resistance.
The liver sinusoidal endothelium undergoes changes in its unique phenotype and
undergoes the process known as capillarization, which is the loss of LSEC fenestration
and development of basement membrane (56). Capillarization has been known to occur
in NAFLD and seen to precede onset of fibrosis (129). LSEC fenestrae are maintained by
VEGF production by hepatocytes and consequent activation of eNOS by the endothelial
cells (130). It has been observed in a previous study that LSEC differentiation plays a
role in the fibrogenesis. LSEC differentiation promotes quiescence of hepatic stellate
cells (HSC) and thereby promotes regression and inhibits progression of liver fibrosis
(57). It has also been observed that the endocytic activity of the LSEC is reduced due to
capillarization (59). All the above observations can be used to draw the following
hypothesis that high fat diet causes the hepatocytes to produce more iNOS that cause
insulin resistance in the endothelial cells and subsequent dysfunction.
The insulin resistance in the LSECs causes it to decrease the eNOS activity,
which causes capillarization. The loss of the phenotype of the LSEC results in the
activation of stellate cells and the fibrogenesis of the liver. The insulin resistance might
also cause the O-GlcNAC addition on the stabilin-2 receptors that lose their ability to
clear HA and other molecules. An insight into the HA secretion and degradation is
necessary to establish the link between the increase in serum HA in liver damage and
sinusoidal endothelial dysfunction.
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Alkaline phosphatase is one of the liver enzymes studied to diagnose liver disease
condition, the other two being the aspartate and alanine aminotransferases. Alkaline
phosphatase is elevated in conditions of hepato-cellular damage and biliary obstruction.
The expression of this enzyme is increased slightly in hepato-cellular damage, and
induced to elevated levels and made into soluble forms especially when the bile ducts are
obstructed (131). This could suggest a possible mechanism where the ductules are
affected. It has also been observed that the alkaline phosphatase levels are increased in
fatty liver disease even though there is no significant increase in triglyceride levels in the
serum, (132). Our experiments also revealed similar observations. Even though rats do
not have a gall bladder, bile is produced by the hepatocytes and secreted into bile ducts
(92). It has also been observed that biliary obstruction results in decreased endocytic
activity in hepatocytes and sinusoidal endothelial cells (93). An investigation between
the sinusoidal endothelial dysfunction and the biliary obstruction is required.
Advanced glycation endproducts (AGE) products are seen to be elevated in
NAFLD (133). The Stab-2 receptor is also involved in the removal of AGE products, as
mentioned previously (29). It is not yet known if the isolated LSECs from HFD rats have
a difference in their ability to remove AGE products, compared to the control diet rats. It
has also been observed that the pre-exposure of the sinusoidal endothelial cells to AGE
can result in decreased endocytic ability of the cells (134). The relation between elevated
AGE and sinusoidal endothelial dysfunction in NAFLD has not yet been explored.
Chronic kidney failure is often associated with NAFLD (135). Deficiency of the
Stabilin receptors in the liver results in glomerular nephritis of the kidney due to ECM
buildup in the glomeruli (136). The link between NAFLD and chronic kidney failure
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because of sinusoidal endothelial dysfunction is not yet known. As the study of the
pathogenesis of NAFLD is a vast field, with new research observations coming in with
each study, the above suggestions will provide a preliminary understanding of the role of
LSEC in the pathogenesis of NAFLD. There are still many unknown molecular events in
the initial stages of NAFLD development and pathogenesis.
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